Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-17

Clinical Trial Update: Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing olanzapine to placebo in outpatients with eating disorders (anorexia nervosa) has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Eating Disorders | Phase 2 | Status: COMPLETED | Results posted: 2009-07-17